These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23439634)

  • 1. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.
    Lahiri SD; Mangani S; Durand-Reville T; Benvenuti M; De Luca F; Sanyal G; Docquier JD
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2496-505. PubMed ID: 23439634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.
    Lahiri SD; Johnstone MR; Ross PL; McLaughlin RE; Olivier NB; Alm RA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5704-13. PubMed ID: 25022578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
    Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
    Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
    Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates.
    Levasseur P; Girard AM; Claudon M; Goossens H; Black MT; Coleman K; Miossec C
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1606-8. PubMed ID: 22214778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
    Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
    ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
    Lahiri SD; Bradford PA; Nichols WW; Alm RA
    J Antimicrob Chemother; 2016 Oct; 71(10):2848-55. PubMed ID: 27402011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel VEB β-Lactamase Enzymes and Their Impact on Avibactam Inhibition.
    Lahiri SD; Alm RA
    Antimicrob Agents Chemother; 2016 May; 60(5):3183-6. PubMed ID: 26926646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
    Castanheira M; Sader HS; Farrell DJ; Mendes RE; Jones RN
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4779-85. PubMed ID: 22733066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of Class A β-Lactamase Inhibition by Relebactam.
    Tooke CL; Hinchliffe P; Lang PA; Mulholland AJ; Brem J; Schofield CJ; Spencer J
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
    Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA
    J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.
    Ehmann DE; Jahić H; Ross PL; Gu RF; Hu J; Kern G; Walkup GK; Fisher SL
    Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11663-8. PubMed ID: 22753474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514.
    Shapiro AB; Gao N; Jahić H; Carter NM; Chen A; Miller AA
    ACS Infect Dis; 2017 Nov; 3(11):833-844. PubMed ID: 28835096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
    Drawz SM; Taracila M; Caselli E; Prati F; Bonomo RA
    Protein Sci; 2011 Jun; 20(6):941-58. PubMed ID: 21404358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the Molecular Basis of Avibactam-Mediated Inhibition of Class A β-Lactamases.
    Das CK; Nair NN
    Chemistry; 2020 Aug; 26(43):9639-9651. PubMed ID: 32285965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam.
    Pozzi C; Di Pisa F; De Luca F; Benvenuti M; Docquier JD; Mangani S
    ChemMedChem; 2018 Jul; 13(14):1437-1446. PubMed ID: 29786960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.